FM-VP4 Forbes Medi-Tech.

Abstract

FM-VP4 is a phytosterol analog under development by Forbes Medi-Tech for the potential treatment of hyperlipidemia and hypercholesterolemia. By March 2002, FM-VP4 had entered phase I clinical trials and phase II trials were underway by late 2002.

• Authors: John R Burnett
• Journal: Current opinion in investigational drugs (London, England : 2000) (Curr Opin Investig Drugs) Vol. 4 Issue 9 Pg. 1120-5 (Sep 2003) ISSN: 1472-4472 [Print] England
• PMID: 14582458 (Publication Type: Journal Article, Review)

Chemical References

• Cholesterol, LDL
• FM-VP4 compound
• Hypolipidemic Agents
• Phytosterols

Topics

• Animals
• Cholesterol, LDL (blood)
• Clinical Trials, Phase I as Topic
• Clinical Trials, Phase II as Topic
• Humans
• Hypercholesterolemia (drug therapy)
• Hyperlipidemias (drug therapy)
• Hypolipidemic Agents (administration & dosage, chemistry, therapeutic use)
• Molecular Structure
• Phytosterols (administration & dosage, chemistry, therapeutic use)
• Randomized Controlled Trials as Topic
• Structure-Activity Relationship